These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9775441)

  • 21. [PAF-acether antagonistic pyrrolo[1,2-c]thiazoles: from RP 48740 to RP 59227].
    Lavé D; James C; Rajoharison H; Floch A; Robaut C; Sedivy P
    J Pharm Belg; 1990; 45(3):219-23. PubMed ID: 2205718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological effect of orally active platelet-activating factor receptor antagonist SM-10661.
    Komuro Y; Imanishi N; Uchida M; Morooka S
    Mol Pharmacol; 1990 Sep; 38(3):378-84. PubMed ID: 2402227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3-(2-(3-Pyridinyl)thiazolidin-4-oyl)indoles, a novel series of platelet activating factor antagonists.
    Sheppard GS; Pireh D; Carrera GM; Bures MG; Heyman HR; Steinman DH; Davidsen SK; Phillips JG; Guinn DE; May PD
    J Med Chem; 1994 Jun; 37(13):2011-32. PubMed ID: 8027984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
    Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The antagonistic effects of khellactones on platelet-activating factor, histamine, and leukotriene D4.
    Aida Y; Kasama T; Takeuchi N; Tobinaga S
    Chem Pharm Bull (Tokyo); 1995 May; 43(5):859-67. PubMed ID: 7553972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel class of platelet activating factor (PAF) antagonists. II. Modification of the 2-position of the glycerol backbone of PAF-sulfonamide isosteres.
    Tsuri T; Matsui T; Haga N; Kamata S; Hagishita S; Takahashi K; Kakushi H; Uchida K; Hatakeyama H; Kurosawa A
    Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):85-95. PubMed ID: 1576692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. YM461, a PAF antagonist, blocks antigen-induced late airway responses and airway hyperresponsiveness in allergic sheep.
    Tomioka K; Garrido R; Ahmed A; Stevenson JS; Abraham WM
    Eur J Pharmacol; 1989 Nov; 170(3):209-15. PubMed ID: 2620695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and modeling of new platelet-activating factor antagonists. 2. Synthesis and biological activity of 1,4-bis-(3',4',5'-trimethoxybenzoyl)-2-alkyl and 2-alkyloxymethylpiperazines.
    Tavet F; Lamouri A; Heymans F; Dive G; Touboul E; Blavet N; Godfroid JJ
    J Lipid Mediat Cell Signal; 1997 Jan; 15(2):145-59. PubMed ID: 9034961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disubstituted tetrahydrofurans and dioxolanes and PAF antagonists.
    Bartrolí J; Carceller E; Merlos M; García-Rafanell J; Forn J
    J Med Chem; 1991 Jan; 34(1):373-86. PubMed ID: 1992139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformational considerations in the design of dual antagonists of platelet-activating factor (PAF) and histamine.
    Kaminski JJ; Carruthers NI; Wong SC; Chan TM; Billah MM; Tozzi S; McPhail AT
    Bioorg Med Chem; 1999 Jul; 7(7):1413-23. PubMed ID: 10465415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonists.
    Curtin ML; Davidsen SK; Heyman HR; Garland RB; Sheppard GS; Florjancic AS; Xu L; Carrera GM; Steinman DH; Trautmann JA; Albert DH; Magoc TJ; Tapang P; Rhein DA; Conway RG; Luo G; Denissen JF; Marsh KC; Morgan DW; Summers JB
    J Med Chem; 1998 Jan; 41(1):74-95. PubMed ID: 9438024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Properties of ABT-299, a prodrug of A-85783, a highly potent platelet activating factor receptor antagonist.
    Albert DH; Conway RG; Magoc TJ; Tapang P; Rhein DA; Luo G; Holms JH; Davidsen SK; Summers JB; Carter GW
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1595-606. PubMed ID: 8667228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
    Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
    Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes.
    Floch A; Tahraoui L; Sedivy P; Cavero I
    J Pharmacol Exp Ther; 1991 Aug; 258(2):567-75. PubMed ID: 1650834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-activity relationships in platelet-activating factor (PAF). 7. Tetrahydrofuran derivatives as dual PAF antagonists and acetylcholinesterase inhibitors. Synthesis and PAF-antagonistic activity.
    Le Texier L; Favre E; Redeuilh C; Blavet N; Bellahsene T; Dive G; Pirotzky E; Godfroid JJ
    J Lipid Mediat Cell Signal; 1996 May; 13(3):189-205. PubMed ID: 8816984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet anti-aggregant activity of 2,2-dimethylthiazolidine hydrochloride and 2-(4-hydroxy-3-methoxyphenyl)thiazolidine.
    Mimura T; Kohama Y; Kuwahara S; Yamamoto K; Komiyama Y; Satake M; Chiba Y; Miyashita K; Tanaka T; Imanishi T
    Chem Pharm Bull (Tokyo); 1988 Mar; 36(3):1110-6. PubMed ID: 3409398
    [No Abstract]   [Full Text] [Related]  

  • 37. Ex vivo effects of SR 27417, a novel PAF antagonist, on rabbit platelet aggregation and [3H]-PAF binding.
    Herbert JM; Laplace MC; Maffrand JP
    J Lipid Mediat; 1992 Feb; 5(1):1-12. PubMed ID: 1327264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PAF binding sites. Characterization by [3H]52770 RP, a pyrrolo[1,2-c]thiazole derivative, in rabbit platelets.
    Robaut C; Durand G; James C; Lave D; Sedivy P; Floch A; Mondot S; Pacot D; Cavero I; Le Fur G
    Biochem Pharmacol; 1987 Oct; 36(19):3221-9. PubMed ID: 2822048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, structure-activity relationships, and pharmacological evaluation of pyrrolo[3,2,1-ij]quinoline derivatives: potent histamine and platelet activating factor antagonism and 5-lipoxygenase inhibitory properties. Potential therapeutic application in asthma.
    Paris D; Cottin M; Demonchaux P; Augert G; Dupassieux P; Lenoir P; Peck MJ; Jasserand D
    J Med Chem; 1995 Feb; 38(4):669-85. PubMed ID: 7861415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of the platelet activating factor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride on endotoxin-induced hypotension and hematological parameters in rats.
    Natsume Y; Imanishi N; Koike H; Morooka S
    Arzneimittelforschung; 1994 Nov; 44(11):1208-13. PubMed ID: 7848333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.